Immune cell and NK cell therapy
What immune cell therapy and NK cell programs are, how they are generally classified in Japan, how the costs are made up, and what to confirm with the clinic before you go.
01What this topic covers
- What immune cell therapy is
- NK cell programs
- Which class it generally falls into
- Self-pay care and cost structure
- Questions to ask the clinic
02Which class it generally falls into in Japan
Immune cell therapy is somatic cell processing without stem cells and is generally Class III (low risk). The class of a specific treatment is whatever the clinic’s submitted plan states.
This is how treatments generally map; the class of a specific treatment is whatever the clinic’s submitted plan states.
Source: Ministry of Health, Labour and Welfare (MHLW), "再生医療・細胞医療・遺伝子治療について" (Regenerative, cell and gene therapy); MHLW division notice, risk-classification chart; checked 2026-11
03Guides in this topic
Immune cell and NK cell therapyAlpha-Beta T, Gamma-Delta T and NK Cells: The Cells Used in Immune Cell TherapyAlpha-beta T, gamma-delta T and NK cells explained: how common each is in blood, how each finds targets, how labs expand them, and how Japan classifies them.
Immune cell and NK cell therapyImmunotherapy in Japan: NK Cell, Dendritic Cell and CAR-T Therapies ComparedHow Japan regulates immunotherapy: approved CAR-T products under pharmaceutical law versus self-pay NK and dendritic cell treatments under the Safety Act.
Immune cell and NK cell therapyNK Cell Therapy: What Natural Killer Cells Do and How Japan Regulates Their UseWhat NK cells do, why most NK cell therapy remains unproven, and how Japan's Safety Act classifies self-pay NK cell treatments by risk class.